Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AnHeart Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
AnHeart Therapeutics

AnHeart Therapeutics

Acquired

AnHeart Therapeutics develops and commercializes innovative pharmaceuticals, focusing on the ROS1/NTRK inhibitor, AB-106.

HQ
New York City, NY, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

AnHeart Therapeutics, founded with a mission to improve human health and quality of life, specializes in developing and commercializing innovative pharmaceutical products. The company focuses on precision oncology therapeutics, particularly targeting cancer treatments. Their flagship product, AB-106, is an oral, highly selective ROS1/NTRK small molecule inhibitor designed to treat specific types of cancer. AnHeart Therapeutics aims to address unmet medical needs in the oncology market by advancing their pipeline of novel therapies.

Notable figures associated with AnHeart Therapeutics include its affiliation with Nuvation Bio, a prominent biopharmaceutical company. Key achievements include the development of clinical-stage assets such as Taletrectinib, a ROS1 inhibitor for non-small cell lung cancer, and Safusidenib, an mIDH1 inhibitor for various tumors. The company's impact is marked by its commitment to precision medicine, offering hope to cancer patients through targeted therapeutic options.

AnHeart Therapeutics - Similar Companies

Anthos Therapeutics logo

Anthos Therapeutics

Palm Therapeutics logo

Palm Therapeutics

Ascenta Therapeutics logo

Ascenta Therapeutics

Hengrui Therapeutics logo

Hengrui Therapeutics

OncXerna Therapeutics logo

OncXerna Therapeutics

oncxerna.com

Athenex logo

Athenex

Anji Pharmaceuticals logo

Anji Pharmaceuticals

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

Anapneo Therapeutics logo

Anapneo Therapeutics

Anthera Pharmaceuticals logo

Anthera Pharmaceuticals

anthera.com

Angarus Therapeutics logo

Angarus Therapeutics

angarustx.com

Angion logo

Angion

elicio.com

Onchilles Pharma logo

Onchilles Pharma

Alphina Therapeutics logo

Alphina Therapeutics

Cardurion Pharmaceuticals logo

Cardurion Pharmaceuticals

AnHeart Therapeutics - Quick Facts

Who are AnHeart Therapeutics' competitors?

Companies similar to AnHeart Therapeutics include Anthos Therapeutics, Palm Therapeutics, Ascenta Therapeutics and Hengrui Therapeutics.

When was AnHeart Therapeutics founded?

AnHeart Therapeutics was founded in 2018.

Where is AnHeart Therapeutics' headquarters located?

AnHeart Therapeutics' headquarters is located in New York City, NY, US.

When was AnHeart Therapeutics' last funding round?

AnHeart Therapeutics' most recent funding round was for $61M (USD) in December 2021.

How much has AnHeart Therapeutics raised to-date?

As of Dec 14, 2021, AnHeart Therapeutics has raised a total of $75.6M (USD).

AnHeart Therapeutics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatments
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified